Primary Care Takeaways From VESALIUS-CV: Evolocumab Efficacy in Patients Without Significant Atherosclerosis
CardiologyPrimary Care Takeaways From VESALIUS-CV: Evolocumab Efficacy in Patients Without Significant Atherosclerosis
Value of of Earlier Lipid-Lowering therapy Intensification with Evolocumab in High-Risk Populations without known significant ASCVD and with Diabetes: VESALIUS-CV Insights
CardiologyValue of of Earlier Lipid-Lowering therapy Intensification with Evolocumab in High-Risk Populations without known significant ASCVD and with Diabetes: VESALIUS-CV Insights
Rethinking Cardiovascular Risk: Uncovering the Blind Spots
Conversations in CV Risk AssessmentRethinking Cardiovascular Risk: Uncovering the Blind Spots
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Heart MattersAthlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
- advertisement
- 5 questions
- advertisement
Rethinking Cardiovascular Risk: Uncovering the Blind Spots
Conversations in CV Risk AssessmentRethinking Cardiovascular Risk: Uncovering the Blind Spots
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Groundbreaking AI Models Transform Cardiovascular Diagnosis
Medical Industry FeatureGroundbreaking AI Models Transform Cardiovascular Diagnosis
Shared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
Medical Industry FeatureShared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
How GLP-1s Provide New Options to Manage Heart Disease
Medical Industry FeatureHow GLP-1s Provide New Options to Manage Heart Disease
- 04/17/2026
- 04/16/2026
- 04/15/2026
- 04/15/2026
- 04/13/2026
- 04/13/2026













































